Slide 1: Financial Results 9 Months 2019
= @ TITAN FA Financial Resulis= 9 Months 2019 wie a 7 November 2019
Slide 2: 2019 9M Highlights
2019 9M Highlights In Q3 the Group recorded growth in Turnover, EBITDA and NPAT. Group Turnover in 9M 2019 increased to €1,209m (+€107m or 9.7%) recording growth across geographies except EMED. EBITDA reached €208m (+€12m or 5.8% vs last year). 9M 2019 Net Profit decreased by 9.9% to €45m, mos
Slide 3: Turnover, EBITDA and NPAT Growth in Q3 2019
Turnover, EBITDA and NPAT Growth in Q3 2019 Group Turnover Group EBITDA Group NPAT € in m illions 9.7% € in m illions 5.8% € in m illions -9.9% 106.6 1,208.5 11.5 208.4 1200 1,101.9 196.9 200 60 50.2 -4.9 900 45.3 150 45 9 Months 600 100 30 300 50 15 0 0 0 Turnover Variance Turnover EBITDA Variance
Slide 4: Sales Volume Growth in USA, SEE and Greece
Sales Volume Growth in USA, SEE and Greece. Further Decline in Egypt, Stabilization Signs in Turkey. 9 Month Sales Volume 13.7 2018A 12.6 2019A -8%(3) +6%(3) 12.6 13.3 -2%(3) 3.98 3.92 Cement (1), (2) Aggregates(2) Ready-mix(2) (tn m) (tn m) (m3 m) * Intragroup product sales for processing are inclu
Slide 5: Bottom Line Recovery Supported by Improved Q3 Performance
Bottom Line Recovery Supported by Improved Q3 Performance In Million Euros, unless otherwise stated 9M 2019 9M 2018 Variance Q3 2019 Q3 2018 Variance Net Sales 1,208.5 1,101.9 9.7% 423.1 389.4 8.7% Cost of Goods Sold -888.0 -802.2 10.7% -301.1 -281.7 6.9% Gross Margin (before depreciation) 320.5 299
Slide 6: Net Debt Higher Due to IFRS 16 Impact and Titan Shares Purchased by TCI
Net Debt Higher (vs Q4 2018) Due to IFRS 16 Impact and Titan Shares Purchased by TCI. Improved OFCF vs 2018. Sources and Uses of Cash 9M Operating Free Cash Flow (€ in millions) 208 4 (75) €87m 200 150 (50) 100 6 (76) 50 (24) (59) (119) 0 -50 (53) -100 -150 EBITDA Non-Cash CapEx Operating Acquisitio
Slide 7: Titan Group Equity Affected by TCI Becoming the New Parent Company
Titan Group Equity Affected by TCI Becoming the New Parent Company. Borrowings Include Lease Liabilities. Variance In Million Euros, unless otherwise stated 30 Sep' 19 30 Sep' 18 31 Dec' 18 30 Sep '19 vs 30 Sep '18 Property, plant & equipment and inv. Property 1,751.9 1,490.2 1,660.1 261.7 Intangibl
Slide 8: Q3 2019 Net Debt Levels Affected by IFRS 16 and TCI
Q3 2019 Net Debt Levels Affected by the Adoption of IFRS 16 and Titan Shares Purchased by TCI Group Net and Gross Debt Evolution (€ in millions) Net debt Gross Debt 1,200 1112 1,100 986988 1,000 930947 874 889 891 900 831 839 787 784 754 758 772 800 739739 732 738 751 707 713 716 723 674 660 650 661
Slide 9: Performance by Region
Performance by Region 9 Months 2019
Slide 10: US Favorable Market Conditions Drive Turnover Growth
US Favorable Market Conditions Drive Turnover Growth USA Turnover USA EBITDA € in m illions 12.9% € in millions 7.1% 750 82.3 721.6 150 9.1 137.0 127.9 639.3 9 Months 500 100 250 50 0 0 Turnover Variance Turnover EBITDA Variance EBITDA 2018 2019 2018 2019 20.0% EBITDA Margin 19.0% US Turnover in 9
Slide 11: Greece Recovery Continued at a Slow Pace
Greece Recovery Continued at a Slow Pace Greece Turnover Greece & Corporate EBITDA € in m illions 6.8% € in m illions 45.1% 750 150 9 Months 500 100 250 11.8 185.2 50 173.4 4.8 15.5 10.7 0 0 Turnover Variance Turnover EBITDA Variance EBITDA 2018 2019 2018 2019 6.1% EBITDA Margin 8.4% Greece & WE T
Slide 12: Sustained Growth in SEE Led to Best Quarterly Performance for Over 5 Years
Sustained Growth in SEE Led to Best Quarterly Performance for Over 5 Years SEE Turnover SEE EBITDA € in m illions 11.2% € in m illions 750 32.6% 150 9 Months 500 100 14.5 59.0 250 175.2 19.5 194.7 50 44.5 0 0 Turnover Variance Turnover EBITDA Variance EBITDA 2018 2019 2018 2019 25.4% EBITDA Margin 3
Slide 13: Market Distortions in Egypt and Turkey Reflected on EMED Financial Performance
Market Distortions in Egypt and Turkey Reflected on EMED Financial Performance EMED Turnover EMED EBITDA € in m illions -6.1% € in m illions 750 140 9 Months 500 90 250 114.0 -7.0 40 107.0 13.9 -16.9 -3.0 0 Turnover Variance Turnover -10 2018 2019 EBITDA Variance EBITDA 2018 2019 12.2% EBITDA Margin
Slide 14: 9M 2019 – Joint Ventures' Performance
9M 2019 – Joint Ventures’ Performance In Brazil, the market has demonstrated demand growth leading to higher YTD cement consumption by 3.0% reaching 40.5MMT (+1.0% in N and NE). Marginal price increases were more than offset by rising transportation costs. Apodi sales revenue has grown by 7% i
Slide 15: Outlook
Outlook 9 Months 2019
Slide 16: Outlook 2019
Outlook 2019 – • Solid fundamentals for further growth. USA • Focus on delivering on both growth and profitability. • Improving outlook for domestic demand. Greece • Focus on cost competitiveness and optimization of exports profitability. • Positive momentum. S.E. Europe • Focus on capturing synergi
Slide 17: Disclaimer
Disclaimer This presentation has been prepared by Titan for informational purposes only. Although the information contained in this presentation has been obtained from sources which Titan believes to be reliable, it has not been independently verified and no representation or warranty, express or im
Slide 18: Thank you
Thank you 18 Investors’ and Analysts’ Presentation 9 Months 2019